Skip to main content
. 2021 Nov 24;12:718763. doi: 10.3389/fphar.2021.718763

TABLE 1.

Characteristics of studies included in the meta-analysis.

Author, publication year, references Country Age (years) Sample size HIV risk groups Year of sample collection Study design (source of data)
Range Median (IQR) or mean ± SD
Kim et al. (2008) Korea 15–75 66 48.5% HTS 2002.03–2005.06 Retrospective cohort study (historic medical records)
46.9% homosexual contact
4.6% Unknown
Castor et al. (2012) The United States 15–69 497 2000–2010.12 Retrospective study (historic medical records)
Yanik et al. (2012) The United States ≥18 43 81% MSM 2000–2010.9 Retrospective cohort study (historic medical and lab records)
19% Unknown
Dai et al. (2014) China 31.8 ± 8.7 266 MSM 2008–2011 Prospective cohort study (medical records)
Ambrosioni et al. (2015) Spain 33 (28–39) 161 82% MSM, 11.8% HTS, 3.1% IDUs, 3.1% unknown 2000–2012 Retrospective cohort study (historic medical records)
Ananworanich et al. (2015) Thailand 28 (24–32) 120 90% MSM, 10% HTS 2009.04.20–2013.09.13 Prospective cohort study (clinic records)
Zhao et al. (2015) China 18–70 367 MSM 2012–2013 Cross-sectional survey (crowd serologic screening)
Stekler et al. (2015) The United States 31 (25–41) 82 MSM 2007–2013 Retrospective cohort study (historic medical records)
Colby et al. (2016) Thailand 28 (23–32) 233 93% MSM, 7% HTS 2009.04.20–2014.12.31 Prospective cohort study (HIV testing centers)
Panichsillapakit et al. (2016) The United States >18 456 2000–2013 Retrospective cohort study (San Diego Primary Infection Cohort)
Rutstein et al. (2019) Malawi >18 45 2012.06–2014.01 Retrospective cohort study (re-analyzing lab samples)
Visseaux et al. (2019) France 36 (28–45) 1,121 70% MSM, 18% HTS, 12% unknown 2014–2016 Retrospective cohort study (re-analyzing lab samples)

Note: MSM, men who have sex with men; HTS, heterosexuals; IDUs, injection drug users; IQR, interquartile range; SD, standard deviation.